Industry

FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, Aug. 10, 2022, … [Read more…]

Atlas’ stealth-stage company will leverage AbCellera’s technology to start and advance new drug programs with enhanced speed and capital efficiency VANCOUVER, British Columbia & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) and Atlas Venture announced a multi-target partnership to discover therapeutic antibodies for up to three drug targets that can be developed and commercialized by a stealth-stage … [Read more…]

– Expect to complete SER-109 Biologics License Application filing in the coming weeks – – Reported confirmatory SER-109 Phase 3 study results, including in individuals with a first recurrence of C. difficile infection – – Strengthened balance sheet with $100 million registered direct equity offering – Conference call at 8:30 a.m. ET today – CAMBRIDGE, … [Read more…]

– Second-Quarter Revenue of $973.1 Million – – Second-Quarter GAAP Earnings per Share of $2.13 and Non-GAAP Earnings per Share of $2.77 – – Reduces 2022 Guidance – WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #CRL–Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2022. For the quarter, revenue was $973.1 million, … [Read more…]

LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2022. Financial Summary and Highlights1 Revenue of $254.2 million for the quarter, decreased 3.9 percent on a reported basis and increased 0.5 percent on a constant-currency basis, as compared to the prior-year period Revenue, … [Read more…]

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2022. Total revenues in the second quarter of 2022 grew 5% year-over-year to $466.9 million, compared to $446.5 million in the second quarter of 2021. “I’m extraordinarily … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present at the Canaccord Genuity 42nd Annual Growth Conference being held August 8-11, 2022. Canaccord Genuity 42nd Annual Growth Conference Date: Wednesday, August 10, 2022 Time: … [Read more…]

Nationally Recognized Fundraising Trailblazer Brittany N. Shaff to Spearhead SFG to Provide Personalized, Digital Approach to Nonprofit, Education, and Healthcare Fundraising and Engagement for Sustainable Philanthropic Growth BALTIMORE–(BUSINESS WIRE)–Shaff Fundraising Group (SFG) announced today its launch to provide strategic philanthropy and engagement management consulting. Partnering with nonprofits, independent schools, higher education, and healthcare organizations, SFG … [Read more…]

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of vaccination for local children and adolescents, the Health Bureau of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China has approved … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, today released a statement regarding results of a jury trial in the patent litigation brought by Magnolia Medical Technologies. Magnolia Medical originally asserted four patents in the case. By the time of the trial, all of these patents were dropped, … [Read more…]